This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
BioPharm America is merging with LSX USA
Hynes Convention Center | Boston, MA

September 11–12, 2024

Matthias Schroff
CEO at Inceptor Bio
Speaker

Profile

Matthias Schroff, PhD, is Inceptor Bio’s Chief Executive Officer. Dr. Schroff has extensive biopharmaceutical leadership experience with a track record of success building companies and developing new medicines in immuno-oncology, inflammatory diseases, and genetic disorders. Dr. Schroff was most recently Chief Executive Officer of Exicure, a publicly traded biotechnology company developing gene regulatory and immunotherapeutic drugs. Dr. Schroff earned a degree in Biochemistry at the University of Leibniz University Hannover and his Doctorate of Molecular Biology from Freie University Berlin.

Agenda Sessions

  • CGT development and commercialization

    1:30pm